This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Union Minister of State for Chemicals and Fertilisers, Anupriya Patel and Secretary, Department of Pharmaceuticals, Amit Agrawal were also present on the occasion. At the initiative of Prime Minister Narendra Modi, March 7 is celebrated every year as Jan Aushadhi Diwas to enhance awareness about the scheme and promote genericmedicines.
The conversation led by Gauri Chaudhari ended with Gauri Chaudhari saying it should be ‘BRANDED & GENERICMEDICINES’. The major issues involved in the NMC decision is the price of branded medicines. In the first place are our branded genericmedicines really expensive? I fully agree with her. Pharm, Ph.D.,
The Indian pharmaceutical sector is loaded with talent and has made great strides in genericmedicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries. In Conclusion, the Union Budget 2025-26 presents a key opportunity to boost Indias pharmaceutical sector.
Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding genericmedicines, beckons for clarity. The establishment of a CPD-supporting entity hinges on fiscal resolutions.
The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). The company offers genericmedicines and biosimilars through Sandoz. appeared first on Pharmaceutical Technology.
The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects.
The pundits are unanimous in their response – changes in the US generic drug market. The US is the biggest market for genericmedicines (~90 per cent of prescriptions are fulfilled by generic drugs). So, a new project should be initiated only when the one being worked on at present is completed.
Astellas has won a reprieve in its attempt to stop Pfizer’s genericmedicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks.
At the end of last year, Pfizer signed an agreement with The Medicines Patent Pool that allowed for its oral antiviral treatment candidate PF-07321332 to be produced and distributed to low- and middle-income countries. In search of solutions.
FDA’s Emerging Technology Program “Advanced manufacturing as a concept, as an initiative, has been very important to the agency,” emphasized workshop presenter Adam Fisher, Ph.D., See also the related Quality Matters blog on industry take-aways from the workshop.]
Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. Our research verified that these countries market NBCPs, including CGx, within the various categories defined by the U.S.
Ingredient and product quality assurance The potential for variation in medical product manufacturing, distribution and regulatory capability across regions and economies can present challenges to ensuring quality and pose threats to patient safety and public health.
Over 70 per cent of these conditions lack a cure and often go unnoticed, presenting a significant opportunity for drug repurposing in India. The high cost and lengthy development process of new drugs, particularly for rare diseases, present significant challenges.
There is no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. India is known as the ‘Pharmacy of the World’, as the genericmedicine supplier for over 200 countries, both developed and emerging markets. How poised are you to leverage them?
Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and genericmedicines.
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global genericmedicines, along with 60 per cent of the total vaccine demand worldwide. For this, a two-pronged approach is necessary.
drug products through policy reforms that reduce risk of disruptions and shortages: Drugs with greater manufacturing complexity, such as sterile injectables, have an increased vulnerability to shortage, according to Medicine Supply Map data presented at the briefing by USP’s Matt Christian. Optimize manufacturing capacity for U.S.
Innovative business models Beyond innovation in manufacturing, innovative business models also can provide potential solutions to medicines supply chain vulnerabilities, as evidenced by Civica. The non-profit maker of essential genericmedicines was established by a group of U.S. Coukell observed.
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most.
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most.
The Future of Generic Drug Development: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drug development.
This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global genericmedicine manufacturers.” Loan License – Using third-party premises on a loan and hire basis.
For example, with skin conditions, textbooks, studies, and trial photos often present lighter-skinned individuals’ symptoms, which are bound to differ in darker skinned individuals. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and genericmedicines.
The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 2 Introducing tariffs on pharmaceutical imports could lead to significant disruptions, particularly for genericmedicines , which often rely on lower-cost API sourcing.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content